Page 21 - Sanket Koul

CBSE Class 10, 12 pass percentages up slightly, still below 2022 peak

Pass percentages for CBSE Class 10 and 12 rose marginally this year to 93.66 per cent and 88.39 per cent respectively, but remained lower than 2022 levels

Trump Residences in Gurugram sells out in a day for Rs 3,250 crore

Apartments priced between Rs 8 crore and Rs 15 crore, with four penthouses at Rs 125 crore each, fully allotted in second Trump-branded project in Gurugram

GSK Pharma Q4 profit rises 35% to ₹263 crore on strong brand growth

GSK Pharma reports 35 per cent YoY rise in Q4FY25 profit led by gains in general medicines and vaccines; oncology launches including Zejula and Jemperli on track

Over 16.6 msf of new malls to come up in Tier-1 cities in 2 yrs: Report

Hyderabad and Delhi- NCR will command a combined 65 per cent share of the new malls

Medtech industry seeks FTA advisory board to counter non-tariff barriers

Industry groups want a joint FTA advisory body to address regulatory hurdles and dumping risks as India negotiates trade deals with the US, EU and UK

India-Pakistan tensions: Uneasy calm on border slows housing pulse

Industry executives and sector observers say developers' strategies will largely depend on demand

Hospitals prepare for emergencies; Aiims, others cancel leave of employees

Centre and state-run hospitals ramp up emergency preparedness amid India-Pakistan conflict with drills, stockpiling, coordination, and deployment of mobile facilities

Continued border tensions may dent housing and commercial realty: Anarock

Anarock expects short-term dip in housing, retail, and hospitality as conflict dampens confidence, while long-term demand and pricing to stabilise once normalcy returns

CDSCO revises export NOC rules for new drugs; sets one-year validity

New CDSCO rules set one-year validity for export NOCs, fix seven-day timeline, and simplify process for unapproved and approved drugs meant solely for export

PB Health raises $218 mn in seed round led by US-based General Catalyst

PB Health, the healthcare venture of PB Fintech, has raised $218 million to set up a 1,000-bed hospital network in Delhi NCR and drive health-tech innovation

Tribeca eyes 8-12 projects in 3 years under new plotted housing arm

Tribeca launches a new vertical, Tribeca Estates, to focus on plotted developments, luxury villas, and hospitality-led townships across key Indian cities

NPPA fixes retail prices of 84 drugs, including empagliflozin combos

The NPPA has fixed retail prices for 84 drug formulations, including 36 combinations of off-patent diabetes drug empagliflozin, after a steep drop in prices

Cabinet approves Rs 11,829-cr expansion of five IITs, 6,576 new seats added

The expansion plan covers IITs in Bhilai, Dharwad, Jammu, Palakkad and Tirupati, adding 6,576 seats and 130 faculty posts with full implementation by FY29

India's pharma market grows 7.8% in April, led by chronic therapies

Chronic therapies and price increases drove 7.8 per cent growth in India's pharma market in April 2025, with cardiac and gastrointestinal segments showing double-digit value gains

Poly Medicure Q4 results: Profit rises 34% on strong exports, new divisions

Poly Medicure posted a 34 per cent rise in Q4 net profit to Rs 91.8 crore, with revenue up 16.6 per cent, driven by strong export performance and new business verticals

Schedule M rollout may face delay as MSMEs seek more time for upgrade

Small drugmakers seek a three-month extension to submit GMP compliance plans under revised Schedule M, raising concerns about delays in national rollout

Pristyn Care opens 3 hospitals in NCR, targets 50 by FY28 public listing

Healthtech firm Pristyn Care moves from asset-light model to hospital ownership, aiming for 50 hospitals, Rs 2,000 crore revenue and 20% Ebitda by FY28 IPO

Oswal Group to invest ₹1,350 crore in Punjab realty over next 3 years

Vardhman Amrante to invest ₹1,350 crore in Punjab, developing commercial spaces and integrated residences in Ludhiana and Bhatinda through internal accruals and sales

MedTech multinationals bet big on India, eyeing global hub status

Global medtech giants like Siemens and Philips are expanding R&D and manufacturing in India, leveraging policy support and talent to embed India in global value chains

Doctors, drugmakers divided over SC's prescribe-only-generics remark

The SC's suggestion to mandate generic-only prescriptions has drawn mixed reactions from the medical and pharma community, highlighting concerns over quality and feasibility